Fig. 6From: A novel signature of two long non-coding RNAs in BRCA mutant ovarian cancer to predict prognosis and efficiency of chemotherapyKEGG and GO analyses. KEGG and GO analyses were performed to investigate the potential involvement of different mRNAs in biological processes occurring in patients harboring BRAC1 and BRAC2 mutationsBack to article page